	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	14/11/2022
	www.isa.gov.il			www.tase.co.il				Reference:	2022-02-109506	Time of broadcast: 15:05 15:05

Immediate Report

Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on

Form 8-K - Medicox License Agreement

Form_8-K_-_Medicox_Agreement_-_November_14_2022_isa.pdf


References of previous documents relating to this matter(the reference does not constitute incorporation by reference):



Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 02/11/2022
Address: Avenue of the Americas 01185 , New York 10036 New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com Company site: www.oramed.com

Previous names of reporting entity:

Name of the Signatory: DEROVAN NETANEL MOSHE Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Mamila 20 , Jerusalem 9414904 Telephone: 02-5660001 Facsimile: E-mail: netanel@oramed.com 1
USA